IRIS
BOSCARO, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.394
EU - Europa 2.953
AS - Asia 917
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 10.299
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.391
UA - Ucraina 817
IE - Irlanda 397
DE - Germania 364
SE - Svezia 347
DK - Danimarca 316
TR - Turchia 299
SG - Singapore 289
IT - Italia 242
FI - Finlandia 174
KR - Corea 166
CN - Cina 146
GB - Regno Unito 132
FR - Francia 114
BE - Belgio 32
CI - Costa d'Avorio 20
IN - India 8
RU - Federazione Russa 8
EU - Europa 6
AU - Australia 3
CA - Canada 3
IR - Iran 3
JP - Giappone 3
MA - Marocco 3
NZ - Nuova Zelanda 3
BG - Bulgaria 2
PL - Polonia 2
AF - Afghanistan, Repubblica islamica di 1
AT - Austria 1
CH - Svizzera 1
ES - Italia 1
LA - Repubblica Popolare Democratica del Laos 1
NL - Olanda 1
NO - Norvegia 1
PK - Pakistan 1
RO - Romania 1
Totale 10.299
Salva come PNG Salva come JPEG
Città #
Chandler 857
Jacksonville 830
Des Moines 705
Boardman 447
Fairfield 423
Dublin 396
Ashburn 349
Wilmington 251
New York 239
Woodbridge 230
Ann Arbor 179
Seattle 179
Lawrence 168
Princeton 168
Houston 158
Cambridge 145
San Mateo 137
Singapore 98
Centro 64
San Diego 55
Brussels 32
Los Angeles 32
Turin 31
Washington 25
Norwalk 23
Abidjan 20
Beijing 19
Civitanova Marche 15
Dallas 15
Falls Church 15
Guangzhou 11
Shanghai 10
Wuhan 10
Helsinki 9
Auburn Hills 7
London 6
Redmond 6
Mumbai 5
Rome 5
Yiwu 5
Ancona 4
Heze 4
Izmir 4
Kilburn 4
Milan 4
Salerno 4
Wuxi 4
Brugherio 3
Filottrano 3
Frankfurt am Main 3
Jiaxing 3
Jinhua 3
Munich 3
New Bedfont 3
Ottawa 3
Porto San Giorgio 3
Pune 3
Quanzhou 3
Siena 3
Chengdu 2
Edinburgh 2
Fars 2
Hangzhou 2
Hanover 2
Montignoso 2
Moscow 2
Otemae 2
Padova 2
Pescara 2
Phoenix 2
Porto 2
Santa Clara 2
Shenzhen 2
Sofia 2
Stockholm 2
Tappahannock 2
Warsaw 2
Yuncheng 2
Acton 1
Adelaide 1
Amsterdam 1
Ascoli Piceno 1
Auckland 1
Borås 1
Brescia 1
Brisbane 1
Chelyabinsk 1
Chiswick 1
Christchurch 1
City of Westminster 1
Clifton 1
Copenhagen 1
Dalian 1
Falkenstein 1
Fayetteville 1
Florence 1
Foresto 1
Gatchina 1
Genova 1
Gillingham 1
Totale 6.503
Salva come PNG Salva come JPEG
Nome #
Prolactinomas,Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas 127
Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors. 125
Persistent psychological distress in patients treated for endocrine disease. 123
ISOLATION AND CHARACTERIZATION OF MESENCHYMAL CELLS FROM PITUITARY TUMOURS 119
Development of overt Cushing's syndrome in patients with adrenal incidentaloma 113
Protective effect of leg fat against cardiovascular risk factors in obese premenopausal women 102
Age-related changes in glucocorticoid fast feedback inhibition of adrenocorticotropin in man. 98
Adrenal incidentaloma: surgical update. 97
Multiple endocrine neoplasia type 1 and adrenal lesions 94
Production of peroxynitrite by human spermatozoa and its possible role on sperm motility. 94
Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. 94
Development of overt Cushing's syndrome in patients with adrenal incidentaloma. 146 (1): 61-66,2002 90
Free thiols in human spermatozoa: involvement of Na/K-ATPase and Ca-ATPase activities in sperm motility. 89
Psychosocial impairment in patients treated for pituitary disease: a controlled study 88
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. 88
Diagnosis and complications of Cushing's syndrome: a consensus statement 87
GH secretagogues and hypothalamo-pituitary-adrenal axis 87
Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas 87
Diagnosis of co-morbid axis-I psychiatric disorders among women with newly diagnosed, untreated endocrine disorders. 87
Aldosterone as a cardiovascular risk factor. 85
Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. 85
Personality characteristics and quality of life in patients treated for Cushing's syndrome 84
Cushing's syndrome 83
Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis. 82
Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse. 81
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. 80
Adipose cell-adrenal interactions: current knowledge and future perspectives. 80
Diabetes mellitus-associated periodontitis: differences between type 1 and type 2 diabetes mellitus. 80
Association of somatotrophinomas with loss of alleles on chromosome 11 and with gps mutations . 79
Correlates of perceived health related quality of life in obese, overweight and normal weight older adults: an observational study 77
Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. 77
Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants. 77
Effects of raloxifene on body fat distribution and lipid profile in healthy post menopausal women 76
Self image and quality of life in acromegaly 76
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. 76
Diagnosis and management of adrenal incidentalomas. 75
Corticotropin-releasing effect of exarelin, a peptyl GH secretagogue in normal subjects pretreated with metyrapone or RU 486, a glucocorticoid receptor antagonist, and patients with Addison's disease 74
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. 74
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma 74
Consideration in diagnosis of Cushing's syndrome 73
Sexual symptoms in endocrine diseases: psychosomatic perspectives. 72
Coenzyme Q10 and male infertility 72
Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase. 72
Effect of the serotonin antagonists ritanserin and ketanserin in Cushing disease 71
Adipose tissue 11 beta-hydrioxysteroid deydrogenase type 1 expression in obesity and Cushing's syndrome 71
Molecolar analysis of CDKN1C and TP53 in sporadic adrenal tumors 71
Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications. 71
Diagnosis of primary aldosteronism: from screening to subtype differentiation 70
Obesity and body mass index (BMI) in ralation to the life style and psycho-social aspects. 70
Chemical-physical properties of lipoproteins in anorexia nervosa. 70
Left ventricular structure and functional characteristic in Cushing's syndrome 69
Effect of natural early menopause on bone mineral density. 69
Endocrine aspects of cancer gene therapy. 69
Comment - Is there a role for low doses of mitotane (o, p'-DDD) as adjuvant therapy in adrenocortical carcinoma? 68
Coenzyme Q10 supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study. 68
Gene therapy for thyroid cancer. 68
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion 68
Recovery of Bone Mineral Density after surgical cure, but not by ketoconazole treatment, in Cushing's syndrome 67
Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease 67
In situ analysis of human menin in normal and neoplastic pancreatic tissues: evidence for differential expression in exocrine and endocrine cells. 67
Expanding role of AMPK in endocrinology 67
Idiopathic infertility: susceptibility of spermatozoa to in vitro capacitation, in the presence and the absence of Palmitylethanolamide (an homologue of Anandamide), is strongly correlated with membrane polarity studied by Laurdan fluorescence. 67
Genetic alterations in medullary thyroid cancer: diagnostic and prognostic markers 67
Obesity and body mass index (BMI) in relation to life-style and psycho-social aspects. 66
New treatment guidelines on Cushing's disease. 66
Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment. 66
Oleoylethanolamide protects human sperm cells from oxidation stress: studies on cases of idiopathic infertility 66
Effect of glucocorticoids on adiponectin:a study in healthy subjects and Cushing's syndrome 66
Adrenal incidentaloma: effects on bone metabolism. 65
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. 65
Improvement of sperm cells motility after CoQ10 treatment in infertile males with idiopathic asthenozoospermia. 65
Genetic mutations in thyroid carcinoma 64
Chemotherapy at the end of life: an open question. 64
Hormonal responses during various phrases of autoimmune adrenal failure: no evidence for 21-hydroxylase enzyme activity inhibition in vivo. 64
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours 64
Bone health and aldosterone excess 64
ADRENAL MORPHO-FUNCTIONAL ALTERATIONS IN PATIENTS WITH ACROMEGALY. 64
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndrome 64
High cardiovascular risk in patients with Cushing's syndrome accorìging to 1999 WHO/ISH guidelines 64
Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation. 64
Adrenocortical carcinoma:experience in 45 patients. 63
Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. 63
Foreword. Glucocorticoid-induced osteoporosis. 62
The diagnosis of Cushing' s syndrome : atypical presentations and laboratory shortcomings 61
Raloxifene and cadiovascular health: its relationschip to lipid and glucose metabolism, hemostatic and inflammation factors and cardiovascular function in postmenopausal women 61
Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists 61
Corticotropin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and Pseudo-Cushing state: a comparative study. 61
Can the ISO9000 quality assessment be applied to the practice of medical oncology? 60
Prevalence and natural history of adrenal incidentalomas. 60
La nutraceutica nell’infertilità maschile. 60
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome 60
A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma. 59
Risk factors and long-term follw-up of adrenal incidentalomas. 59
Fine-needle aspiration cytology of adrenal masses: a re-assessment with histological confirmation. 59
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial 59
Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome 59
Small tumor size as favorable prognostic factor after adrenalectomy in Conn's adenoma 58
Cortical adrenal mitochondrial morphology changes in functional state: new insights. 58
Brief report: A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma 57
Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism. 57
Totale 7.426
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.893
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020934 0 0 170 4 170 14 169 5 177 2 6 217
2020/20212.066 86 265 404 22 236 79 223 93 228 115 231 84
2021/20221.131 50 239 9 64 19 93 39 74 82 135 83 244
2022/20232.866 202 221 173 211 217 897 0 183 594 10 114 44
2023/20241.387 254 40 72 233 229 303 18 49 0 32 9 148
2024/2025458 134 207 117 0 0 0 0 0 0 0 0 0
Totale 10.388